NEW ORLEANS — Two substudies from the COAPT trial presented at the American College of Cardiology Scientific Session found that patients with moderate-to-severe or severe aortic regurgitation who had transcatheter mitral valve repair and guideline-directed medical therapy had improvements in health status as soon as 1 month.
However, an echocardiographic substudy was not able to find predictors of improved status beyond right ventricular systolic pressure in patients who had transcatheter mitral valve repair.
As Cardiology Today’s Intervention previously reported, in the main

Source link